NO901461L - Antistoffer mot retinoblastom-genprodukt og anvendelse derav. - Google Patents

Antistoffer mot retinoblastom-genprodukt og anvendelse derav.

Info

Publication number
NO901461L
NO901461L NO90901461A NO901461A NO901461L NO 901461 L NO901461 L NO 901461L NO 90901461 A NO90901461 A NO 90901461A NO 901461 A NO901461 A NO 901461A NO 901461 L NO901461 L NO 901461L
Authority
NO
Norway
Prior art keywords
retinoblastom
reproduct
antibodies against
determining
retinoblastoma
Prior art date
Application number
NO90901461A
Other languages
English (en)
Other versions
NO179328C (no
NO179328B (no
NO901461D0 (no
Inventor
Yuen Kai Fung
Ang Anne T
Original Assignee
Canji Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canji Inc filed Critical Canji Inc
Publication of NO901461D0 publication Critical patent/NO901461D0/no
Publication of NO901461L publication Critical patent/NO901461L/no
Publication of NO179328B publication Critical patent/NO179328B/no
Publication of NO179328C publication Critical patent/NO179328C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4736—Retinoblastoma protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cosmetics (AREA)
NO901461A 1989-03-31 1990-03-30 Antistoffer mot retinoblastom-genprodukt, anvedelse derav samt murint hybridom NO179328C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33208289A 1989-03-31 1989-03-31

Publications (4)

Publication Number Publication Date
NO901461D0 NO901461D0 (no) 1990-03-30
NO901461L true NO901461L (no) 1990-10-01
NO179328B NO179328B (no) 1996-06-10
NO179328C NO179328C (no) 1996-09-18

Family

ID=23296661

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901461A NO179328C (no) 1989-03-31 1990-03-30 Antistoffer mot retinoblastom-genprodukt, anvedelse derav samt murint hybridom

Country Status (15)

Country Link
EP (1) EP0390530B1 (no)
JP (1) JPH04193900A (no)
KR (1) KR0175658B1 (no)
CN (1) CN1046759A (no)
AT (1) ATE122723T1 (no)
AU (1) AU638238B2 (no)
CA (1) CA2013544C (no)
DE (1) DE69019410T2 (no)
FI (1) FI901618A0 (no)
IE (1) IE63277B1 (no)
IL (1) IL93941A (no)
NO (1) NO179328C (no)
NZ (1) NZ233147A (no)
PT (1) PT93619A (no)
ZA (1) ZA902425B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710255A (en) * 1992-07-14 1998-01-20 Canji, Inc. Characterization of a novel anti-p110RB monoclonal antibody
US5550020A (en) * 1994-07-08 1996-08-27 Visible Genetics Inc. Method, reagents and kit for diagnosis and targeted screening for retinoblastoma
US5545527A (en) 1994-07-08 1996-08-13 Visible Genetics Inc. Method for testing for mutations in DNA from a patient sample
DE69739276D1 (de) * 1996-04-05 2009-04-09 Antonio Giordano Methoden zur diagnose und prognose von krebs
US5840506A (en) * 1996-06-05 1998-11-24 Thomas Jefferson University Methods for the diagnosis and prognosis of cancer
EP1594459B1 (en) 2002-12-30 2010-02-17 Angiotech International Ag Drug delivery from rapid gelling polymer composition
TW200741009A (en) 2005-07-01 2007-11-01 Oncotherapy Science Inc Methods of modulating SMYD3 for treatment of cancer
CN102053150B (zh) * 2009-10-30 2013-07-17 上海交通大学医学院附属瑞金医院 一种人成骨肉瘤干细胞相关抗原标记物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE168135T1 (de) * 1988-01-21 1998-07-15 Massachusetts Eye & Ear Infirm Diagnose von retinoblastoma

Also Published As

Publication number Publication date
AU5246190A (en) 1990-10-04
CA2013544C (en) 2001-02-06
FI901618A0 (fi) 1990-03-30
AU638238B2 (en) 1993-06-24
KR900013987A (ko) 1990-10-22
DE69019410T2 (de) 1995-10-05
IE63277B1 (en) 1995-04-05
CN1046759A (zh) 1990-11-07
KR0175658B1 (ko) 1999-03-20
CA2013544A1 (en) 1990-09-30
DE69019410D1 (de) 1995-06-22
PT93619A (pt) 1990-11-20
EP0390530B1 (en) 1995-05-17
ZA902425B (en) 1991-01-30
IL93941A (en) 1995-03-30
NO179328C (no) 1996-09-18
IL93941A0 (en) 1990-12-23
IE901179L (en) 1990-09-30
NZ233147A (en) 1993-04-28
EP0390530A1 (en) 1990-10-03
NO179328B (no) 1996-06-10
JPH04193900A (ja) 1992-07-13
NO901461D0 (no) 1990-03-30
ATE122723T1 (de) 1995-06-15

Similar Documents

Publication Publication Date Title
DE3882847D1 (de) Verfahren zur unmittelbaren bestimmung physikalischer eigenschaften von kohlenwasserstoffprodukten.
AU1062700A (en) Antibody-serum protein hybrids
CA2082382A1 (en) Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy
FI885543A0 (fi) Dna-segment, polypeptider och anti-kroppar anslutande till human vaevnadsfaktor.
ATE169640T1 (de) Arzneimittelzusammensetzung zur behandlung oder vorbeugung maligner tumore
DE69223284D1 (de) Methoden zur Bestimmung von Krebsmetastasen mittels Nukleinsäuren-Amplifikation
DK0733069T3 (da) Oprensede Primat CTLA-8-antigener og beslægtede reagenser
GR1000477B (el) Νεο μονοκλωνικο αντισωμα κατα νεου αντιγονου που σχετιζεται με ανθρωπινους ογκους.
DE3881715D1 (de) Produkt fuer schleifzwecke.
AU7079396A (en) Anti-galalpha(1,3)gal antibody binding peptides
EP0102381A4 (en) METHOD FOR IDENTIFYING AND CLEANING ANTIGENS (hLTAA) ASSOCIATED WITH HUMAN LUNG TUMOR AND CLINICALLY DETECTING AND DETERMINING THIS ANTIGENS.
DK113389A (da) Monoklonale antistoffer
ATE82835T1 (de) Eiweissprodukt.
PT91075A (pt) Processo para a preparacao de imunoconjungados de gelonina com anticorpos especificos de tumor apropriados para o diagnostico e a terapeutica do cancro
NO901461L (no) Antistoffer mot retinoblastom-genprodukt og anvendelse derav.
DE3888998D1 (de) Verfahren zur Bestimmung eines Antikörpers in menschlichen Körperflüssigkeiten.
DE3783966D1 (de) Reagens zur pruefung von periodentalen erkrankungen.
DE3874387D1 (de) Immunologische methoden und materialien zur bestimmung von tumor assoziierten antigenen.
HK1021228A1 (en) In vitro method for determining the presence of hepatocellular carcinoma
DE69823660D1 (de) Methode zur identifizierung von tumorantigenen mit autoantikörpern in serum
SE9002212D0 (sv) Igg binding protein
DE59004279D1 (de) Verfahren zur C-terminalen Modifizierung von Proteinen.
DE68907377D1 (de) Agens und geraet zur bestimmung von antigenen oder antikoerpern.
DE58907208D1 (de) Verfahren zur Bestimmung von Antikörpern.
ATE103073T1 (de) Verfahren zur bestimmung von antikoerpern.